Time for Top Leaders to Join Pandemic Negotiations
Two final – and likely sleepless – weeks of negotiation on the pandemic agreement began on Monday 18 March, and negotiators have been urged to bring in their principals to ensure speed up decision-making.
European Patients’ Rights Day: Addressing skills shortage, medical desertification and job strain
Ahead of European Patients’ Rights Day, Mariano Votta, Director of Active Citizenship Network, discusses how the event will tackle the skills shortage, medical desertification and job strain in the healthcare sector.
European Immunization Week 2024: Prevent. Protect. Immunise
WHO European Region celebrates the European Immunization Week in April to promote awareness of the importance of immunisation in preventing diseases and protecting life.
COVID-19 Shows Why the World Needs a Pandemic Agreement
Dr. Tedros Adhanom Ghebreyesus on how we must prepare now to counter the threat of a future pandemic.
Overcoming the COVID-19 pandemic together and building a Health Union
In 2020, the world was hit by the worst pandemic of our generation. At the heart of the European Commission’s response to COVID-19 were cooperation and solidarity.
Call for expression of interest – Members representing non-governmental organisations in the Advisory Forum of the European Centre for Disease Prevention and Control
The European Commission has launched a call for expression of interest aiming at the selection of the ECDC Advisory Forum members.
Cryptic proteins translated from deletion-containing viral genomes dramatically expand the influenza virus proteome
Evaluation of the effectiveness and impact of Nirsevimab in Galicia
The purpose of NIRSE-GAL is to evaluate the impact of the inclusion of nirsevimab in the Galician immunisation schedule on the prevention of Respiratory Syncytial Respiratory Syncytial Virus (RSV) infections in children.
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1
COVID-19 vaccines have recently been updated to specifically encode or contain the spike protein of the SARS-CoV-2 XBB.1.5 subvariant.
Perception of government performance during COVID-19 not linked to death rate.
People living in the United States are more likely to report that their government handled the COVID-19 pandemic ‘well’ than any other G7 nation despite having the highest death rate, according to a new report from the Global Listening Project.
Article
News
Scientific Papers
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort
The protection of fourth dose mRNA vaccination against SARS-CoV-2 is relevant to current global policy decisions regarding ongoing booster roll-out.